Medios AG
ILM1
Rank in Stocks
#14735
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Share Price
$12.38
Last synced: 2026-11-12
Market Cap
$303.36M
Change (1 day)
-2.42%
Change (1 year)
-28.70%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medios AG (ILM1)
Category
Healthcare
EPS for Medios AG (ILM1)
EPS as of June 2026 TTM: $0.49
According to Medios AG's latest financial reports, its current EPS (TTM) is $0.49. At the end of 2025 the company had an EPS of $0.72, an increase over its 2024 EPS of $0.53.
EPS history for Medios AG from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.49 | -31.85% |
| 2025 | $0.72 | 34.86% |
| 2024 | $0.53 | -39.23% |
| 2023 | $0.87 | 5.73% |
| 2022 | $0.83 | 96.34% |
| 2021 | $0.42 | -4.04% |
| 2020 | $0.44 | -41.68% |
| 2019 | $0.75 | 111.03% |
| 2018 | $0.36 | -7.24% |
| 2017 | $0.38 | -149.99% |
| 2016 | $-0.77 | 102.13% |
| 2015 | $-0.38 | 331.33% |
| 2014 | $-0.09 | -83.57% |
| 2013 | $-0.54 | -15.30% |
| 2012 | $-0.63 | -831.18% |
| 2011 | $0.09 | 0.00% |
| 2010 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | 7,858.02% |
US
|
|
| $17.99 | 3,566.19% |
US
|
|
| $7.77 | 1,483.45% |
US
|
|
| $17.99 | 3,566.19% |
US
|
|
| $0.04 | -91.14% |
AU
|
Questions about Medios AG's earnings per share (EPS)
What is Medios AG's earnings per share (EPS)?
Medios AG's earnings per share (EPS) over the last twelve months is $0.49, as of Jun 2026.
What was Medios AG's earnings per share (EPS) in 2025?
In 2025, Medios AG's earnings per share (EPS) was $0.72, 35.85% more than in 2024 ($0.53).
How has Medios AG's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Medios AG's earnings per share (EPS) went from $0.44 to $0.72, an average growth of 10.35% a year.
How does Medios AG's earnings per share (EPS) compare with similar companies?
Medios AG's earnings per share (EPS) ($0.49) is higher than that of 1 of the 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.